1-2 of 2
Maureen A. Joyce
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensive Treatment Strategies May Not Provide Superior Outcomes in Mantle Cell Lymphoma: Overall Survival Exceeding Seven Years in a Large Cohort of Patients Managed Primarily with Conservative Therapies.

Peter Martin, MD, Amy Chadburn, MD, Paul Christos, Richard R. Furman, MD, Jia Ruan, Maureen A. Joyce, Patricia Glynn, Ruben Niesvizky, Eric J. Feldman, Tsiporah B. Shore, Michael W. Schuster, Scott Ely, Daniel Knowles, Selina Chen-Kiang, Morton Coleman, John P. Leonard
Journal: Blood
Blood (2007) 110 (11): 1362.
https://doi.org/10.1182/blood.V110.11.1362.1362
Published: 2007
Journal Articles

Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results.

John P. Leonard, MD, Richard R. Furman, MD, Ying-Kuen K. Cheung, Ph.D, Eric J. Feldman, MD, Hearn J. Cho, M.D, PhD, Julie M. Vose, MD, Gwen Nichols, MD, Patricia W. Glynn, Maureen A. Joyce, Jamie Ketas, Jia Ruan, MD, PhD, John Carew, MD, Ruben Niesvizky, MD, Ann LaCasce, MD, Amy Chadburn, MD, Ethel Cesarman, MD, PhD, Morton Coleman, MD
Journal: Blood
Blood (2005) 106 (11): 491.
https://doi.org/10.1182/blood.V106.11.491.491
Published: 2005